Related Experiment Video
Updated: May 31, 2026
06:16
Generation of Orthotopic Pancreatic Tumors and Ex vivo Characterization of Tumor-Infiltrating T Cell Cytotoxicity
Published on: December 7, 2019
Antitumor cell activity in vitro by myristoylated-peptide
1Department of Biological Sciences, University of Memphis, Memphis, TN 38152-3560, USA. ddourth@memphis.edu
Summary
A novel N-myristoylated-peptide shows significant anticancer activity, inhibiting over 50% of tumor cell growth in 34 cell lines. This natural product derivative is a promising candidate for new cancer treatments.
Area of Science:
- Oncology
- Natural Products Chemistry
- Drug Discovery
Background:
- Cancer is characterized by uncontrolled tumor cell proliferation, necessitating the development of new anticancer drugs.
- Current treatments often involve agents that inhibit tumor cell growth.
- N-myristoylated-peptide is a natural product from insect hemolymph with demonstrated antitumor properties and low cytotoxicity to normal cells.
Purpose of the Study:
- To evaluate the in vitro antitumor activity of a synthesized N-myristoylated-peptide against a panel of human tumor cell lines.
- To identify specific cancer types sensitive to the myristoylated-peptide.
Main Methods:
- A synthesized six-amino acid N-myristoylated-peptide was tested at 10 μM.
- In vitro antitumor activity was assessed against 56 human tumor cell lines using the National Cancer Institute (NCI) screening assay.
- Tumor cell growth inhibition was measured.
Main Results:
- The myristoylated-peptide demonstrated significant antitumor activity, inhibiting growth by over 50% in 34 out of 56 tested human tumor cell lines.
- The compound showed the best overall activity (>60% average growth inhibition) against non-small cell lung cancer, leukemia, and melanoma cell lines.
- Sensitivity was observed across eight major tumor types.
Conclusions:
- The synthesized N-myristoylated-peptide exhibits broad-spectrum in vitro antitumor activity.
- The NCI's in vitro screening method effectively identifies compounds with potential in vivo antitumor efficacy.
- This myristoylated-peptide is a promising lead compound for the development of novel anticancer therapeutics.
Related Concept Videos
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...